Scarica l'app Stockscreener
58.74
4.14%
-2.54
Dopo l'orario di chiusura:
58.56
-0.18
-0.31%
Precedente Chiudi:
$61.28
Aprire:
$59.87
Volume 24 ore:
5.47M
Relative Volume:
0.86
Capitalizzazione di mercato:
$10.66B
Reddito:
$1.36B
Utile/perdita netta:
$-302.91M
Rapporto P/E:
-34.19
EPS:
-1.7182
Flusso di cassa netto:
$-219.93M
1 W Prestazione:
-9.16%
1M Prestazione:
+6.68%
6M Prestazione:
+15.40%
1 anno Prestazione:
-24.85%
Intervallo 1D:
$58.02
$61.11
Intervallo di 1 settimana:
$58.02
$66.30
Portata 52W:
$40.77
$104.32
Tempus Ai Inc Stock (TEM) Company Profile
Nome
Tempus Ai Inc
Settore
Industria
Telefono
800-976-5448
Indirizzo
600 WEST CHICAGO AVENUE, CHICAGO
Compare TEM vs VEEV, BTSG, TXG, HQY
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TEM
Tempus Ai Inc
|
58.74 | 11.13B | 1.36B | -302.91M | -219.93M | -1.7182 |
VEEV
Veeva Systems Inc
|
260.98 | 42.23B | 3.32B | 941.65M | 1.64B | 5.6161 |
BTSG
Brightspring Health Services Inc
|
57.88 | 12.27B | 13.65B | 169.86M | 412.12M | 1.0758 |
TXG
10 X Genomics Inc
|
66.38 | 8.77B | 638.78M | -22.66M | 122.18M | -0.1744 |
HQY
Healthequity Inc
|
94.55 | 7.66B | 1.34B | 230.70M | 440.96M | 2.6695 |
Tempus Ai Inc Stock (TEM) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-04-13 | Iniziato | Jefferies | Underperform |
| 2026-04-13 | Aggiornamento | TD Cowen | Hold → Buy |
| 2026-02-19 | Iniziato | Mizuho | Outperform |
| 2026-02-17 | Iniziato | Robert W. Baird | Outperform |
| 2025-12-02 | Ripresa | Morgan Stanley | Overweight |
| 2025-10-21 | Downgrade | TD Cowen | Buy → Hold |
| 2025-10-20 | Iniziato | Canaccord Genuity | Buy |
| 2025-09-02 | Iniziato | H.C. Wainwright | Buy |
| 2025-04-21 | Iniziato | BTIG Research | Buy |
| 2025-02-25 | Downgrade | JP Morgan | Overweight → Neutral |
| 2025-02-12 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2025-02-05 | Ripresa | TD Cowen | Buy |
| 2024-12-13 | Iniziato | Wolfe Research | Outperform |
| 2024-12-09 | Iniziato | Guggenheim | Buy |
| 2024-11-11 | Downgrade | Stifel | Buy → Hold |
| 2024-10-02 | Downgrade | BofA Securities | Buy → Neutral |
| 2024-08-12 | Iniziato | Piper Sandler | Neutral |
| 2024-07-09 | Iniziato | BofA Securities | Buy |
| 2024-07-09 | Iniziato | JP Morgan | Overweight |
| 2024-07-09 | Iniziato | Longbow | Buy |
| 2024-07-09 | Iniziato | Loop Capital | Buy |
| 2024-07-09 | Iniziato | Morgan Stanley | Overweight |
| 2024-07-09 | Iniziato | Needham | Buy |
| 2024-07-09 | Iniziato | Stifel | Buy |
| 2024-07-09 | Iniziato | TD Cowen | Buy |
| 2024-07-09 | Iniziato | William Blair | Outperform |
Mostra tutto
Tempus Ai Inc Borsa (TEM) Ultime notizie
Top Artificial Intelligence Stocks To ResearchSeptember 10th - MarketBeat
Tracking Cathie Wood: Loading Up on Gene-Editing BEAM、NTLA, Trimming Googl and Tempus AI - Moomoo
Tempus AI wins up to $9.5 million ARPA-H ADVOCATE award for autonomous heart failure agent - Bitget
Tempus Secures Up to $9.5 Million in ARPA-H ADVOCATE Funding to Deploy First Autonomous AI in Cardiology - 01net
Top Artificial Intelligence Stocks To Follow NowSeptember 9th - MarketBeat
UBS Initiates Coverage on Tempus AI With Neutral Rating, $70 Price Target - Moomoo
Tempus AI (NASDAQ:TEM) Now Covered by Analysts at UBS Group - MarketBeat
Tempus AI (NASDAQ:TEM) Upgraded to Hold at Rothschild & Co Redburn - MarketBeat
TEM Stock On Track For Best Week In 4 Months Following Personalis Deal Spotlight - Stocktwits
Rothschild Redburn initiates Tempus AI stock coverage at Neutral By Investing.com - Investing.com Australia
Tempus AI (NASDAQ:TEM) Coverage Initiated at Roth Capital - MarketBeat
Rothschild Redburn initiates Tempus AI stock coverage at Neutral - Investing.com
Tempus AI gets FDA clearance for pulmonary hypertension AI tool - scanx.trade
The Cure for Cancer is Becoming an Investable Opportunity: Analyst Sees $600 Million for Tempus AI - CryptoRank
Tempus AI (NASDAQ:TEM): Can Growth Outrun Rate Risks? - Kalkine Media
Best Artificial Intelligence Stocks To ConsiderSeptember 7th - MarketBeat
Weekly Recap: Intismeran win and Personalis 13% stake backs Tempus AI - TradingView
Cathie Wood's weekly recap: loads Rocket Lab, Block; cuts Palantir, Tempus AI (ARKK:BATS) - Seeking Alpha
Tempus AI, Inc. $TEM Shares Acquired by Washington Trust Advisors Inc. - MarketBeat
Public Employees Retirement System of Ohio Makes New $1.77 Million Investment in Tempus AI, Inc. $TEM - MarketBeat
Tempus AI, Inc. (TEM) Stock Analysis: Navigating Volatility With A 21.6% Revenue Growth - DirectorsTalk Interviews
Tracking Cathie Wood: Loading Up on Gene Editing and Precision Medicine, Trimming Tempus AI and Synthetic Biology - Moomoo
Wellington Management Group LLP Sells 123,748 Shares of Tempus AI, Inc. $TEM - MarketBeat
Personalized Cancer Vaccine Breakthrough Ignites Sequencing Sector, Tempus AI's Personalis Bid Faces Rivalry Speculation - finance.biggo.com
Tempus AI Stock (TEM) Opinions on Analyst Upgrades and Personalized Medicine Momentum - Quiver Quantitative
Tempus to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference - Business Wire
Tempus AI Director Jennifer A. Doudna Sells 676 Shares Under Rule 10b5-1 Plan - Kalkine Media
Tempus AI Data CEO Ryan Fukushima's Spouse Executes $30,846 Share Sale via 10b5-1 Plan - Kalkine Media
Tempus AI (TEM) CEO's spouse sells 30,846 shares under trading plan - Stock Titan
Tempus AI (TEM) director’s stock sale follows preset plan - Stock Titan
Tempus AI (TEM) director sells 676 shares under preset plan - Stock Titan
Artificial Intelligence Stocks Worth WatchingSeptember 3rd - MarketBeat
Tempus AI Got an $80 Target and 28% Upside Call. Is Wall Street Underestimating Its Healthcare Data Moat? - finance.yahoo.com
Tempus AI's Data Business Is Priced Like a Vendor, Not a Platform, Analyst Says - Benzinga
Cantor Fitzgerald initiates Tempus AI stock with overweight rating By Investing.com - Investing.com Australia
Artificial Intelligence Stocks To Watch TodaySeptember 2nd - MarketBeat
Tempus AI gains as Cantor issues new Overweight on Data and applications segment - Seeking Alpha
Tempus AI Director Nadja West Sells 3,000 Shares for $207,000 - The Motley Fool
Tempus AI (NASDAQ:TEM) Coverage Initiated by Analysts at Cantor Fitzgerald - MarketBeat
Cantor Fitzgerald initiates Tempus AI stock with overweight rating - Investing.com
Cantor Fitzgerald Initiates Tempus AI at Overweight With $80 Price Target - marketscreener.com
Analysts Offer Insights on Healthcare Companies: Tempus AI, Inc. Class A (TEM) and Assembly Biosciences (ASMB) - The Globe and Mail
Cathie Wood's Investment Moves on September 1! Significantly Increased Stake in Rocket Lab, Reduced Holdings in Tempus AI - Moomoo
Tempus AI Inc (Derivatives) to Euro Price Today | Live TEM to EUR Converter & Exchange Rate - CryptoRank
Cathie Wood Sells $15.6 Million of Tempus AI Stock After Merck-Moderna Trial Win, Ark Keeps Selling AMD Shares - Benzinga
Tempus AI Director Nadja West Sells 3,000 Class A Shares Under Rule 10b5-1 Plan - Kalkine Media
Nadja West Sells 3,000 Shares of Tempus AI (NASDAQ:TEM) Stock - MarketBeat
Tempus AI (TEM) director sells 3K shares, still holds 31,981 - Stock Titan
Tempus AI Inc (Derivatives) to Japanese Yen Price Today | Live TEM to JPY Converter & Exchange Rate - CryptoRank
Tempus AI (NASDAQ:TEM) Shares Gap UpShould You Buy? - MarketBeat
Tempus AI stock upgraded at Piper Sandler (TEM:NASDAQ) - Seeking Alpha
Tempus Ai Inc Azioni (TEM) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
6.63%
2.04%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):